Start with three questions: “What exactly are you proposing for my diagnosis?” “What have human studies found in people like me?” “What are the risks, and who will help if something goes wrong?” Before you decide, ask for the treatment plan in writing, including its approval or study status, standard-care alternatives, total costs, and follow-up.
This article is general information only and is not personal medical advice. Bring your questions and your records to a qualified physician who can assess your own condition.

Start With Your Diagnosis
Before discussing any cell product, confirm the exact diagnosis and how certain it is — similar symptoms can have different causes, so ask what finding supports it.
What to ask
- What diagnosis explains my symptoms, and what is still uncertain?
- What stage is my condition at, and how is it changing?
- Am I likely to be suitable for this exact treatment, and why or why not?
- Is there anything in my history that needs closer review, such as infection, cancer history, heart or lung disease, kidney or liver problems, bleeding risk, medicines that affect immunity or clotting, or pregnancy?
- Do I need more tests, scans, or a specialist opinion before anyone can decide?
- What would count as a reason to postpone or not proceed?
A useful answer names the diagnosis and points to the supporting test result or finding. If the doctor cannot do that yet, ask what record or test is missing. Be cautious if the discussion starts with a package price before your diagnosis is clear, or if you are told that everyone with your symptom is suitable.
It helps to write down one or two concrete goals — for example: walk for 20 minutes with less knee pain, climb stairs with fewer stops, or sleep through the night with less back pain.
Ask What Treatment Is Proposed
“Stem cell therapy” alone does not name a treatment. The same words are sometimes used for cell types, sources, processing methods, doses, and delivery routes that differ a great deal.
What to ask
- What is the name of the cell type or product being considered?
- Where do the cells come from — my own body or a donor?
- If tissue needs to be collected, how is it collected and what does that involve?
- Are the cells cultured or processed in another way, and where does that happen?
- How are the cells given — for example, injection into a joint, infusion into a vein, or another route — and to which part of the body?
- How many sessions are proposed, over what period, and what happens between sessions?
- Who will perform each step, and will the doctor I meet now also be involved in my care?
Ask the doctor to write down the proposed dose as well. If the product or how it will be given is still undecided, ask what information is needed to finalize the plan. If the proposal involves your own cells or donor cells, the distinction between autologous and allogeneic stem cells can help you frame questions about screening and matching.
A blood-forming stem cell transplant in cancer care is something different from a clinic injection for joint pain or anti-aging. The National Cancer Institute describes these transplants as procedures that restore blood-forming stem cells after high-dose chemotherapy or radiation, most often used for blood cancers such as leukemia, lymphoma, and multiple myeloma. [1]
Evidence for a transplant does not establish that a different cell preparation works for another condition or when given another way.
Ask What Evidence Supports It
Laboratory results, animal studies, and stories about other patients cannot by themselves show that a treatment improves symptoms or daily function in people with your condition.
What to ask
- What human studies support this exact product and route for my diagnosis and stage?
- Who was studied — age, condition, previous treatment — and how many people took part?
- Was there a comparison group, and what happened to people who did not receive the cells?
- What improved — pain, movement, daily activities, or only a laboratory or imaging measure — and by how much?
- How long were people followed, and did any benefit last?
- What side effects and serious adverse events occurred?
A change on a scan or in a blood marker does not necessarily mean you will feel or function better. Short follow-up can leave lasting benefits and delayed side effects uncertain.
For a clinical trial, ask who can join, what participation involves, and who oversees it. A registry entry identifies a study; it does not show that the intervention works.
Ask About Risks and Aftercare
Risks depend on the exact steps — collection of tissue, processing, injection or infusion, anesthesia if used, and any change to your current medicines.
What to ask
- What are the common and serious risks of this specific plan for someone with my health background?
- What safety checks are needed before treatment, such as blood tests, infection screening, heart assessment, or cancer follow-up?
- Do I need to pause, change, or continue any current medicines, and who decides that?
- What symptoms after treatment need urgent care, and who do I contact day and night?
- Who manages complications, and what happens if I am already back home?
- How are side effects recorded and followed up?
Do not stop prescribed medicines unless the prescribing clinician advises it. Tell the doctor about all prescription medicines, over-the-counter medicines, supplements, allergies, previous operations, and previous regenerative or cell-based treatments.
Using your own cells does not make a procedure risk-free. In its warning about unapproved regenerative medicine products, the U.S. FDA lists reactions at collection or administration sites and contamination during processing among the possible risks [2]. If you are considering care in Japan, use this guide to discussing stem cell treatment safety in Japan to prepare questions about those steps and who will handle complications.
Ask About Approval and Trial Status
Ask two separate questions: Is the product approved for the proposed use in the country where you would receive it? Is the doctor offering it as part of a trial or outside one? If a product is approved, check whether the approved use covers your situation.
For example, the U.S. FDA lists Ryoncil (remestemcel-L-rknd) for steroid-refractory acute graft-versus-host disease in children aged 2 months and older. “Steroid-refractory” means the condition has not responded adequately to steroids. The FDA’s indication does not cover joint pain or anti-aging [3]. The FDA’s list of licensed cell and gene therapy products identifies individual products; check the product’s own label for the approved use [4].
In Japan, the Act on the Safety of Regenerative Medicine and the PMD Act serve different purposes: the former regulates regenerative medical practice and research within its scope, while the latter governs marketing approval of regenerative medical products. Filing a provision plan is not product approval and does not establish that the treatment works [5].
What to ask
- Is the product approved for my condition here, and would I receive it in a trial or outside one?
- If approval is claimed, what is the product name and the approved use?
- If a trial is proposed, what is the registration number and what are my rights as a participant?
- If it is a clinic service, what documents describe the plan, the evidence and uncertainties, the risks, and the alternatives?
- In Japan, if the Act on the Safety of Regenerative Medicine applies, what is the provision-plan number and what does the plan actually cover?
Keep a copy of the paperwork for your own doctor to review. If the Japanese clinic gives you a plan number, ask it to show you the matching entry; this guide to regenerative medicine paperwork in Japan explains what to compare.
Ask About Alternatives
What to ask
- What standard treatments are still available for my condition?
- What do rehabilitation, medicines, surgery, monitoring, or continued current care offer in my case?
- What happens if I delay a standard treatment to try this approach?
- Is there a less invasive step worth trying first?
- If this cell treatment is not advised, what should I discuss next with my usual doctor?
Further assessment, standard care, or simply monitoring for now is sometimes the right answer. A written proposal to consider is not consent to treatment.
Ask About Costs and Visits
Ask for an itemized quote so you can compare what is included. For care in Japan, use this checklist for a written stem cell treatment quote to flag charges that need clarification.
What to ask
- What does the quoted price include — consultation, tests, collection, processing, storage, administration, and follow-up?
- Is the price per session or for a full course, and how many sessions are likely?
- What happens to the price if assessment shows treatment should not go ahead?
- Which costs are excluded, including treatment of complications?
- How many visits are needed, how long should I allow, and which steps require being there in person?
- What follow-up is planned, what will be measured and when, and what counts as no benefit?
- What records will I receive to share with my local doctor, and in which language?
If you are traveling for care, ask which decisions can be made remotely, which require an in-person exam or further tests, and which steps are scheduled on different days.
What to Bring to the Appointment
- Your latest specialist report and any confirmed or suspected diagnosis
- Relevant scan reports and, if asked, the original images rather than only the written interpretation
- Recent laboratory results with dates, units, and reference ranges
- A list of current medicines and doses, supplements, allergies, and previous operations
- A short timeline: when symptoms started, whether they are stable or changing, what treatment you tried, and what helped or did not help
- What you can and cannot do now in daily life
Use the date the test was actually done to judge how recent it is, not the date a report was translated or sent. If your condition has changed since the last test, say so. You do not need to arrange extra scans or blood tests on your own just to complete a set — ask which ones the doctor needs and why.
Also ask about the practical details — whether you will see a treating physician or a support coordinator, whether interpretation is available if you need it, how much time to allow, and how to send records securely.
How to Follow Up on Vague Answers
For example, suppose you ask about follow-up and hear, “You can always call us.” Ask: “If I’m already home and have a problem outside your office hours, who should I call? Can you write down when I should seek local urgent care instead of waiting for a reply?”
After the visit, mark each answer as clear, pending, or unanswered. For anything pending, note who will provide the answer and by when. Bring those notes and the written plan if you seek a second opinion.
Consultation Checklist
| Question group | A clear answer includes | Reasons to pause |
|---|---|---|
| Diagnosis and fit | Named diagnosis, stage, reason you may or may not be suitable | Everyone with your symptom is suitable |
| Exact product and route | Cell type, source, processing, dose, route, sessions, who does what | No product or route can be named |
| Human evidence | Who was studied, comparison, what improved, follow-up length, adverse events | Only lab, animal, or story evidence |
| Risks and aftercare | Common and serious risks, safety checks, urgent symptoms, and who to contact | Risks are dismissed or no one is named to handle complications |
| Status and paperwork | Approved use if claimed, trial number if applicable, and any clinic plan documents | Filing alone presented as proof it works |
| Alternatives | Standard options, what waiting changes, less invasive steps | No alternative is discussed |
| Costs and visits | Itemized inclusions, per-session or course, exclusions, visit plan | One headline price with no breakdown |
| Follow-up | What is measured, by when, what counts as no benefit, records for your local doctor | No follow-up measure or timeline |
When to Pause
Ask for more time and speak with your usual doctor or another qualified physician if:
- A guaranteed result, regrowth, or cure is promised
- You are discouraged from seeking standard care or a second opinion
- You are asked to pay in full before anyone can name the product, explain the evidence and risks, and put the plan in writing
- Approval, registration, or certification is used as proof that the treatment works for your condition
- Risks are missing from the discussion, or urgent symptoms and aftercare have no clear owner
- The pressure to decide comes from a discount deadline rather than your medical situation
Bottom Line
Before you pay or travel, check the written plan against your notes. If you cannot verify what is being offered, why it is being proposed, or who would handle complications, get a second medical opinion before committing.
If you are planning a consultation in Japan, use the contact page to ask about appointment logistics and how to share records securely.
Ask about consultation logistics




